CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-09 | Behbahani Ali Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2022-06-09 | Treco Douglas A Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2022-06-09 | High Katherine A Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2022-06-09 | Greene John Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2022-06-09 | George Simeon Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2022-06-09 | Fardis Maria Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2022-06-09 | Fleming Harold Edward Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2022-06-09 | Bolzon Bradley J PhD Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2022-05-23 | Morrow Phuong Khanh Chief Medical Officer | Grant or award · Restricted Stock Units | +27,750 | 27,750 | ||
| 2022-05-23 | Morrow Phuong Khanh Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2022-03-14 | Kulkarni Samarth Chief Executive Officer | Shares withheld for taxes | −4,153 | $61.08 | $254K | 290,279 |
| 2022-03-14 | Klein Lawrence Otto CBO & COO | Shares withheld for taxes | −1,229 | $61.08 | $75K | 26,797 |
| 2022-03-14 | KASINGER JAMES R. General Counsel and Secretary | Shares withheld for taxes | −1,039 | $61.08 | $63K | 46,429 |
| 2022-03-11 | Kulkarni Samarth Chief Executive Officer | Shares withheld for taxes | −5,487 | $62.56 | $343K | 285,432 |
| 2022-03-11 | Kulkarni Samarth Chief Executive Officer | Option exercise | +9,000 | 294,432 | ||
| 2022-03-11 | Kulkarni Samarth Chief Executive Officer | Option exercise · Restricted Stock Units | −9,000 | 27,000 | ||
| 2022-03-11 | Klein Lawrence Otto CBO & COO | Shares withheld for taxes | −1,883 | $62.56 | $118K | 25,026 |
| 2022-03-11 | Klein Lawrence Otto CBO & COO | Option exercise | +3,000 | 28,026 | ||
| 2022-03-11 | Klein Lawrence Otto CBO & COO | Option exercise · Restricted Stock Units | −3,000 | 9,000 | ||
| 2022-03-11 | KASINGER JAMES R. General Counsel and Secretary | Shares withheld for taxes | −1,321 | $62.56 | $83K | 45,218 |
Page 22 of 46 · 910 trades